2019 Dec 16th, New Technology Add-on Payment Town Hall meeting (Afternoon Session)

Times are Subject to Change Presentations are 15-minutes including Q&A. 1:15-1:30p 10 lisocabtagene maraleucel Presenter: Tina Albertson, MD PhD, Vice President, Clinical Sciences, Juno Therapeutics, a Bristol-Myers-Squibb Company Jun T 1:35-1:50p 11 EluviaTM Drug-Eluting Vascular Stent System Presenter: Juan Diaz-Cartelle, MD 1:55-2:10p 12 The SpineJack® system Presenter: Dr. Douglas Beall Chief of Operations of The Spine Fracture Institute, LLC Chief of Radiology Services Clinical Radiology of Oklahoma 2:15-2:30p 13 Hemospray® Endoscopic Hemostat Presenter: Seth A. Gross, MD, FACG, FASGE Associate Professor of Medicine, Chief of Gastroenterology, Tisch Hospital, NYU Langone Health 2:35-2:50p 14 ZULRESSO Presenter: Koji Takahashi, Associate Director, Medical Science Liaisons, Sage Therapeutics, Inc 2:55-3:10p 15 The GammaTile™ Presenter: David Brachman, MD Chief Technology Officer GT Medical Technologies 3:15-3:30p 16 IMFINZI (Durvalumab) Presenter: Jonathan Goldman, MD Associate Professor, UCLA Hematology & Oncology Associate Director of Drug Development Director of Clinical Trials in Thoracic Oncology 3:35-3:50p 17 WAVELINQ The WavelinQ™ EndoAVF System Presenter: Dr. Todd Berland 3:55-4:10p 18 XENLETA™ (lefamulin) Presenter: Elizabeth Alexander, MD, MS Senior Director, Clinical Development Nabriva Therapeutics Senior 4:15-4:30p 19 CONTEPO Presenter: Elizabeth Alexander, MD, MS Senior Director, Clinical Development Nabriva Therapeutics